title: Immune complexes of LDL induce atherogenic responses in human monocytic cells.
abstract: The ability of immune complexes of LDL or acetylated LDL (acLDL), together with antibodies to LDL, to induce a proatherogenic phenotype in human monocytic cells has been explored. Treatment of THP-1 monocytic cells or peripheral human monocytes with LDL immune complexes containing intact anti-LDL markedly enhanced the ability of these cells to subsequently bind and take up LDL, whereas aggregated LDL or LDL immune complexes prepared with F(ab')2 fragments of anti-LDL had no significant effect. Activation of THP-1 cells with intact LDL immune complexes also stimulated mRNA expression for the scavenger receptor. Additionally, activation of THP-1 cells with insoluble immune complexes of LDL or LDL stimulated generation of reactive oxygen intermediates that, in turn, could oxidize exogenous LDL. These results indicate that the binding of lipoprotein immune complexes to Fc receptors on monocytic cells activates a series of responses that could accelerate the initiation or progression of atherosclerosis.
authors.affiliation: Department of Autoimmunity and Transplantation, Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, USA.
authors.forename: P A
authors.initials: PA
authors.lastname: Kiener
authors.forename: B M
authors.initials: BM
authors.lastname: Rankin
authors.forename: P M
authors.initials: PM
authors.lastname: Davis
authors.forename: S A
authors.initials: SA
authors.lastname: Yocum
authors.forename: G A
authors.initials: GA
authors.lastname: Warr
authors.forename: R I
authors.initials: RI
authors.lastname: Grove
mesh_terms: D000936:Antigen-Antibody Complex / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000276:immunology*; D001483:Base Sequence; D002232:Carbocyanines; D005456:Fluorescent Dyes; D006801:Humans; D007951:Leukemia, Myeloid; D008077:Lipoproteins, LDL / Q000276:immunology* / Q000494:pharmacology*; D008565:Membrane Proteins; D008969:Molecular Sequence Data; D009000:Monocytes / Q000187:drug effects / Q000276:immunology*; D010084:Oxidation-Reduction; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis; D017452:Receptors, IgG / Q000276:immunology; D011971:Receptors, Immunologic / Q000235:genetics; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D014407:Tumor Cells, Cultured
chemical_list: D000936:Antigen-Antibody Complex; D002232:Carbocyanines; D005456:Fluorescent Dyes; D008077:Lipoproteins, LDL; D008565:Membrane Proteins; D012333:RNA, Messenger; D017452:Receptors, IgG; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B; C024286:3,3'-dioctadecylindocarbocyanine